journal article·2015-02-24

Peptide Nanofiber Complexes with siRNA for Deep Brain Gene Silencing by Stereotactic Neurosurgery

Mariarosa Mazza, Marilena Hadjidemetriou, Irene de Lázaro, Cyrill Bussy, Kostas Kostarelos

ACS Nano· Volume 9· Issue 2
Publisher page

Abstract

Peptide nanofibers (PNFs) are one-dimensional assemblies of amphiphilic peptides in a cylindrical geometry. We postulated that peptide nanofibers (PNFs) can provide the tools for genetic intervention and be used for delivery of siRNA, as they can be engineered with positively charged amino acids that can electrostatically bind siRNA. The aim of this work was to investigate the use of PNFs as vectors for siRNA delivery providing effective gene knockdown. We designed a surfactant-like peptide (palmitoyl-GGGAAAKRK) able to self-assemble into PNFs and demonstrated that complexes of PNF:siRNA are uptaken intracellularly and increase the residence time of siRNA in the brain after intracranial administration. The biological activity of the complexes was investigated in vitro by analyzing the down-regulation of the expression of a targeted protein (BCL2), as well as induction of apoptosis, as well as in vivo by analyzing the relative gene expression upon stereotactic administration into a deep rat brain structure (the subthalamic nucleus). Gene expression levels of BCL2 mRNA showed that PNF:siBCL2 constructs were able to silence the target BCL2 in specific loci of the brain. Silencing of the BCL2 gene resulted in ablation of neuronal cell populations, indicating that genetic interventions by PNF:siRNA complexes may lead to novel treatment strategies of CNS pathologies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Supramolecular Self-Assembly in Materials · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanomedicine Lab, Institute of Inflammation and Repair, Faculty of Medical & Human Sciences, AV Hill Building, The University of Manchester, Manchester M13 9PT United Kingdom

Funding

European Commission Directorate-General for Research and Innovation · Engineering and Physical Sciences Research Council · University Of Manchester

References (54)

Show source-provided references
1. Pardridge W. M. · J. Cereb. Blood Flow Metab. · 2012 · 32 · 195910.1038/jcbfm.2012.126 ↗
2. Boudreau R. L. · Hum. Mol. Genet. · 2011 · 20 · R2110.1093/hmg/ddr137 ↗
3. Dessy A. · Clin. Pharmacol. Ther. · 2011 · 89 · 45010.1038/clpt.2010.312 ↗
4. Kanasty R. · Nat. Mater. · 2013 · 12 · 96710.1038/nmat3765 ↗
5. Coursindel T. · Nucleic Acid Ther. · 2012 · 22 · 7110.1089/nat.2012.0341 ↗
6. Bates K. · Adv. Drug. Delivery Rev. · 2013 · 65 · 202310.1016/j.addr.2013.10.003 ↗
7. Musacchio T. · Front. Biosci. · 2013 · 18 · 5810.2741/4087 ↗
8. Burnett J. C. · Chem. Biol. · 2012 · 19 · 6010.1016/j.chembiol.2011.12.008 ↗
9. Gindy M. E. · Drug Delivery · 2012 · 9 · 171
10. Dehsorkhi A. · J. Pept. Sci. · 2014 · 20 · 45310.1002/psc.2633 ↗
11. Hartgerink J. D. · Science · 2001 · 294 · 168410.1126/science.1063187 ↗
12. Cui H. · Biopolymers · 2010 · 94 · 110.1002/bip.21328 ↗
13. Pashuck E. T. · Sci. Transl. Med. · 2012 · 4 · 160sr16410.1126/scitranslmed.3002717 ↗
14. Hartgerink J. D. · Proc. Natl. Acad. Sci. U.S.A. · 2002 · 99 · 513310.1073/pnas.072699999 ↗
15. Tysseling-Mattiace V. M. · J. Neurosci. · 2008 · 28 · 381410.1523/JNEUROSCI.0143-08.2008 ↗
16. Silva G. A. · Science · 2004 · 303 · 135210.1126/science.1093783 ↗
17. Ellis-Behnke R. G. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 505410.1073/pnas.0600559103 ↗
18. 10.1016/j.nano.2014.05.01210.1016/j.nano.2014.05.012 ↗
19. Palmgren B. · Exp. Neurol. · 2012 · 235 · 59910.1016/j.expneurol.2012.03.014 ↗
20. Mazza M. · ACS Nano · 2013 · 7 · 101610.1021/nn305193d ↗
21. Wagh A. · Nanomedicine:NBM · 2013 · 9 · 44910.1016/j.nano.2012.10.009 ↗
22. Mazza M. · Faraday Discuss. · 2013 · 166 · 18110.1039/c3fd00100h ↗
23. Bulut S. · Biomacromolecules · 2011 · 12 · 300710.1021/bm200641e ↗
24. Levy O. A. · Apoptosis · 2009 · 14 · 47810.1007/s10495-008-0309-3 ↗
25. Laakkonen P. · Integr. Biol. · 2010 · 2 · 32610.1039/c0ib00013b ↗
26. Kostarelos K. · Nat. Nanotechnol. · 2007 · 2 · 10810.1038/nnano.2006.209 ↗
27. Shalek A. K. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 187010.1073/pnas.0909350107 ↗
28. Robertson J. D. · ACS Nano · 2014 · 8 · 465010.1021/nn5004088 ↗
29. Gilleron J. · Nat. Biotechnol. · 2013 · 31 · 63810.1038/nbt.2612 ↗
30. Lacerda L. · Biomaterials · 2012 · 33 · 333410.1016/j.biomaterials.2012.01.024 ↗
31. Al-Jamal K. T. · Proc. Natl. Acad. Sci. U.S.A. · 2011 · 108 · 1095210.1073/pnas.1100930108 ↗
32. Beniash E. · Acta Biomater. · 2005 · 1 · 38710.1016/j.actbio.2005.04.002 ↗
33. Standley S. M. · Cancer Res. · 2010 · 70 · 302010.1158/0008-5472.CAN-09-3267 ↗
34. Agrawal A. · ACS Nano · 2009 · 3 · 249510.1021/nn900201e ↗
35. Yang J. · Science · 1997 · 275 · 112910.1126/science.275.5303.1129 ↗
36. Kuwana T. · Curr. Opin. Cell. Biol. · 2003 · 15 · 69110.1016/j.ceb.2003.10.004 ↗
37. Porter A. G. · Cell Death Differ. · 1999 · 6 · 9910.1038/sj.cdd.4400476 ↗
38. Li Y. · Stroke · 1995 · 26 · 125210.1161/01.STR.26.7.1252 ↗
39. Lee S. H. · Eur. J. Pharm. Biopharm. · 2013 · 85 · 510.1016/j.ejpb.2013.03.021 ↗
40. Sakurai Y. · Biomaterials · 2011 · 32 · 573310.1016/j.biomaterials.2011.04.047 ↗
41. Lundberg P. · FASEB J. · 2007 · 21 · 266410.1096/fj.06-6502com ↗
42. Rahbek U. L. · J. Gene Med. · 2008 · 10 · 8110.1002/jgm.1120 ↗
43. Youn P. · Mol. Pharmaceutics · 2014 · 11 · 48610.1021/mp400446v ↗
44. Eguchi A. · Nat. Biotechnol. · 2009 · 27 · 56710.1038/nbt.1541 ↗
45. Garcia I. · Science · 1992 · 258 · 30210.1126/science.1411528 ↗
46. Chen J. · J. Cereb. Blood Flow Metab. · 2000 · 20 · 103310.1097/00004647-200007000-00002 ↗
47. Obeso J. A. · Mov. Disord. · 2008 · 23 · S54810.1002/mds.22062 ↗
48. Limousin P. · Lancet · 1995 · 345 · 9110.1016/S0140-6736(95)90062-4 ↗
49. Alexander G. E. · Trends. Neurosci. · 1990 · 13 · 26610.1016/0166-2236(90)90107-L ↗
50. Benabid A. L. · Lancet Neurol. · 2009 · 8 · 6710.1016/S1474-4422(08)70291-6 ↗
51. Paxinos G. · 1996
52. McCormack A. L. · PLoS One · 2010 · 5 · 1
53. Ojala D. S. · Neuroscientist · 2015 · 21 · 8410.1177/1073858414521870 ↗
54. Marks W. J. · Lancet Neurol. · 2010 · 9 · 116410.1016/S1474-4422(10)70254-4 ↗